Please see the resources below to learn more about the issues surrounding the use of biosimilars.
May 3, 2016
A guest post from Robert Yapundich, M.D. and Gregory Schimizzi, M.D. Read More ›
April 12, 2016
The biosimilars age has arrived with the promise of an expanding array of therapeutic options for patients and physicians battling serious diseases and conditions. As prescribers of biologics, we believe that realizing the biosimilar promise requires awareness of the differences between biosimilars and generics, and among biologics themselves, as well as an understanding of the distinctive therapeutic choices they represent. This introductoary handbook provides an overview of the key issues. Read More ›